As we start to see the increased, routine, use of multiparametric magnetic resonance imaging (mpMRI) to inform prostate cancer diagnosis and image-guided biopsy, data collected from University College London Hospital describes the expected diagnostic outcomes of PSA and PSA Density in this pathway as well as the potential space remaining for novel biomarkers to further improve the pathway. The gene discussed is KLK3; the disease is prostate carcinoma.